Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

Nomogram for Predicting Survival for Oral Squamous Cell Carcinoma

  • Kim, Ki-Yeol (Oral Cancer Research Institute, College of Dentistry, Yonsei University) ;
  • Li, Sheng-Jin (Oral Cancer Research Institute, College of Dentistry, Yonsei University) ;
  • Cha, In-Ho (Oral Cancer Research Institute, College of Dentistry, Yonsei University)
  • Accepted : 2010.11.25
  • Published : 2010.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

An accurate system for predicting the survival of patients with oral squamous cell carcinoma (OSCC) will be useful for selecting appropriate therapies. A nomogram for predicting survival was constructed from 96 patients with primary OSCC who underwent surgical resection between January 1994 and June 2003 at the Yonsei Dental Hospital in Seoul, Korea. We performed univariate and multivariate Cox regression to identify survival prognostic factors. For the early stage patients group, the nomogram was able to predict the 5 and 10 year survival from OSCC with a concordance index of 0.72. The total point assigned by the nomogram was a significant factor for predicting survival. This nomogram was able to accurately predict the survival after treatment of an individual patient with OSCC and may have practical utility for deciding adjuvant treatment.

Keywords

References

  1. Bianco, F.J.Jr. (2006). Nomograms and medicine. Eur. Urol. 50, 884-886. https://doi.org/10.1016/j.eururo.2006.07.043
  2. Epstein, J.B., Sciubba, J., Silverman, S.Jr., and Sroussi, H.Y. (2007). Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck 29, 948-958. https://doi.org/10.1002/hed.20637
  3. Galli, P., Cadoni, G., Volante, M., De Feo, E., Amore, R., Giorgio, A., Arzani, D., Paludetti, G., Ricciardi, G., and Boccia, S. (2009). A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer 9, 137. https://doi.org/10.1186/1471-2407-9-137
  4. Goulart, J.A., Nonaka, C.F., da Costa, M.C., de Almeida, R., and Galvao, H.C. (2009). Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma. Am. J. Otolaryngol. 30, 89-94. https://doi.org/10.1016/j.amjoto.2008.02.012
  5. Hoang, T., Xu, R., Schiller, J.H., Bonomi, P., and Johnson, D.H. (2005). Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J. Clin. Oncol. 23, 175-183. https://doi.org/10.1200/JCO.2005.04.177
  6. Karakiewicz, P.I., Briganti, A., Chun, F.K., Trinh, Q.D., Perrotte, P., Ficarra, V., Cindolo, L., De la Taille, A., Tostain, J., Mulders, P. F., Salomon, L., Zigeuner, R., Prayer-Galetti, T., Chautard, D., Valeri, A., Lechevallier, E., Descotes, J.L., Lang, H., Mejean, A., and Patard, J.J. (2007). Multi-institutional validation of a new renal cancer-specific survival nomogram. J. Clin. Oncol. 25, 1316-1322. https://doi.org/10.1200/JCO.2006.06.1218
  7. Kattan, M.W., Eastham, J.A., Stapleton, A.M., Wheeler, T.M., and Scardino, P.T. (1998). A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J. Natl. Cancer Inst. 90, 766-771. https://doi.org/10.1093/jnci/90.10.766
  8. Kattan, M.W., Wheeler, T.M., and Scardino, P.T. (1999). Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J. Clin. Oncol. 17, 1499-1507.
  9. Kim, H.L., Seligson, D., Liu, X., Janzen, N., Bui, M.H., Yu, H., Shi, T., Figlin, R.A., Horvath, S., and Belldegrun, A.S. (2004). Using protein expressions to predict survival in clear cell renal carcinoma. Clin. Cancer Res. 10, 5464-5471. https://doi.org/10.1158/1078-0432.CCR-04-0488
  10. Kim, M.S., Lee, S.Y., Lee, T.R., Cho, W.H., Song, W.S., Koh, J.S., Rouzier, R., Preti, M., Haddad, B., Martin, M., Micheletti, L., and Paniel, B.J. (2009). Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann. Oncol. 20, 955-960. https://doi.org/10.1093/annonc/mdn723
  11. Myoung, H., Kim, M.J., Lee, J.H., Ok, Y.J., Paeng, J.Y., and Yun, P.Y. (2006). Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int. J. Oral Maxillofac. Surg. 35, 1005-1010. https://doi.org/10.1016/j.ijom.2006.07.016
  12. Pisani, P., Parkin, D.M., Bray, F., and Ferlay, J. (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83, 18-29.
  13. Rouzier, R., Preti, M., Haddad, B., Martin, M., Micheletti, L., and Paniel, B.J. (2006). Development and validation of a nomogram for predicting outcome of patients with vulvar cancer. Obstet. Gynecol. 107, 672-677. https://doi.org/10.1097/01.AOG.0000198639.36855.e9
  14. Rouzier, R., Pusztai, L., Delaloge, S., Gonzalez-Angulo, A.M., Andre, F., Hess, K.R., Buzdar, A.U., Garbay, J.R., Spielmann, M., Mathieu, M.C., Symmans, W.F., Wagner, P., Atallah, D., Valero, V., Berry, D.A., and Hortobagyi, G.N. (2005). Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J. Clin. Oncol. 23, 8331-8339. https://doi.org/10.1200/JCO.2005.01.2898
  15. Shah, N.G., Trivedi, T.I., Tankshali, R.A., Goswami, J.V., Jetly, D.H., Shukla, S.N., Shah, P.M., and Verma, R.J. (2009). Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis. Head Neck 31, 1544-1556. https://doi.org/10.1002/hed.21126
  16. Smith, J., Rattay, T., McConkey, C., Helliwell, T., and Mehanna, H. (2009). Biomarkers in dysplasia of the oral cavity: A systematic review. Oral Oncol. 45, 647-653. https://doi.org/10.1016/j.oraloncology.2009.02.006
  17. Stephenson, A.J., Scardino, P.T., Eastham, J.A., Bianco, F.J.Jr., Dotan, Z.A., DiBlasio, C.J., Reuther, A., Klein, E.A., and Kattan, M.W. (2005a). Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J. Clin. Oncol. 23, 7005-7012. https://doi.org/10.1200/JCO.2005.01.867
  18. Stephenson, A.J., Smith, A., Kattan, M.W., Satagopan, J., Reuter, V.E., Scardino, P.T., and Gerald, W.L. (2005b). Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer 104, 290-298. https://doi.org/10.1002/cncr.21157
  19. Sudbo, J., Reith, A. (2005). The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int. J. Cancer 115, 339-345. https://doi.org/10.1002/ijc.20896